Cosette Launches First US Generic To AbbVie’s Rectiv
Commercial Shipments To Commence Imminently, With 180 Days Of CGT Exclusivity
Approval of Cosette’s first US generic to Rectiv came with a six-month exclusivity as the originator drug had “inadequate generic competition,” but the company has 75 days to enter the market.
